Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CDK7 anticorps (AA 1-80)

CDK7 Reactivité: Humain, Souris, Rat WB, ELISA, IHC (p), IF (cc), IHC (fro), IF (p), FACS Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN670251
  • Antigène Voir toutes CDK7 Anticorps
    CDK7 (Cyclin-Dependent Kinase 7 (CDK7))
    Épitope
    • 32
    • 13
    • 7
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-80
    Reactivité
    • 99
    • 28
    • 12
    • 6
    • 5
    • 5
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Humain, Souris, Rat
    Hôte
    • 79
    • 21
    • 1
    Lapin
    Clonalité
    • 73
    • 28
    Polyclonal
    Conjugué
    • 54
    • 7
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp CDK7 est non-conjugé
    Application
    • 75
    • 34
    • 33
    • 18
    • 14
    • 13
    • 13
    • 11
    • 9
    • 8
    • 7
    • 6
    • 3
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Flow Cytometry (FACS)
     Réactivité croisée
    Humain, Souris, Rat
    Homologie
    Cow
    Purification
    Purified by Protein A.
    Immunogène
    KLH conjugated synthetic peptide derived from human CDK7
    Isotype
    IgG
    Top Product
    Discover our top product CDK7 Anticorps primaire
  • Indications d'application
    WB 1:300-5000
    ELISA 1:500-1000
    FCM 1:20-100
    IHC-P 1:200-400
    IHC-F 1:100-500
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 μg/μL
    Buffer
    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
    Date de péremption
    12 months
  • Antigène
    CDK7 (Cyclin-Dependent Kinase 7 (CDK7))
    Autre désignation
    CDK7 (CDK7 Produits)
    Synonymes
    anticorps CAK1, anticorps CDKN7, anticorps HCAK, anticorps MO15, anticorps STK1, anticorps p39MO15, anticorps AI323415, anticorps AI528512, anticorps C230069N13, anticorps Cdkn7, anticorps Crk4, anticorps CD 7, anticorps CDK7, anticorps CG3319, anticorps DmCDK7, anticorps DmCdk7, anticorps DmMO15, anticorps DmMo15, anticorps Dmcdk7, anticorps Dmel\\CG3319, anticorps Mo15, anticorps cdk-7, anticorps cdk7, anticorps dCdk7, anticorps p40[MO15], anticorps p40MO15, anticorps stk1, anticorps zgc:85821, anticorps cak1, anticorps cdkn7, anticorps p39mo15, anticorps cyclin dependent kinase 7, anticorps cyclin-dependent kinase 7, anticorps Cyclin-dependent kinase 7, anticorps cyclin-dependent kinase 7 L homeolog, anticorps CDK7, anticorps Cdk7, anticorps cdk7.L, anticorps cdk7
    Sujet

    Synonyms: CAK1, HCAK, MO15, STK1, CDKN7, p39MO15, Cyclin-dependent kinase 7, 39 kDa protein kinase, p39 Mo15, CDK-activating kinase 1, Cell division protein kinase 7, Serine/threonine-protein kinase 1, TFIIH basal transcription factor complex kinase subunit, CDK7, CAK

    Background: Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of CDK1/cyclin-B during G2-M transition, and for activation of CDK2/cyclins during G1-S transition (but not complex formation). CDK7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. Phosphorylates SPT5/SUPT5H, SF1/NR5A1, POLR2A, p53/TP53, CDK1, CDK2, CDK4, CDK6 and CDK11B/CDK11. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminal domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts. Phosphorylation of POLR2A in complex with DNA promotes transcription initiation by triggering dissociation from DNA. Its expression and activity are constant throughout the cell cycle. Upon DNA damage, triggers p53/TP53 activation by phosphorylation, but is inactivated in turn by p53/TP53, this feedback loop may lead to an arrest of the cell cycle and of the transcription, helping in cell recovery, or to apoptosis. Required for DNA-bound peptides-mediated transcription and cellular growth inhibition.

    ID gène
    1022
    UniProt
    P50613
    Pathways
    Cycle Cellulaire, Réparation de l'ADN, Intracellular Steroid Hormone Receptor Signaling Pathway, Mitotic G1-G1/S Phases, M Phase
Vous êtes ici:
Support technique